Severe Enteropathy and Hypogammaglobulinemia Complicating Refractory Mycobacterium tuberculosis Complex Disseminated Disease in a Child with IL-12Rβ1 Deficiency (original) (raw)

Abstract

Purpose

Mendelian susceptibility to mycobacterial disease is a rare clinical condition characterized by a predisposition to infectious diseases caused by poorly virulent mycobacteria. Other infections such as salmonellosis and candidiasis are also reported. The purpose of this article is to describe a young boy affected with various infectious diseases caused by Mycobacterium tuberculosis complex, Salmonella sp, Klebsiella pneumonie, Citrobacter sp., and Candida sp, complicated with severe enteropathy and transient hypogammaglobulinemia.

Methods

We reviewed medical records and performed flow cytometry staining for lymphocyte populations, lymphocyte proliferation in response to PHA, and intracellular IFN-γ production in T cell PHA blasts in the patient and a healthy control. Sanger sequencing was used to confirm the genetic variants in the patient and relatives.

Results

Genetic analysis revealed a bi-allelic mutation in IL12RB1 (C291Y) resulting in complete IL-12Rβ1 deficiency. Functional analysis demonstrated the lack of intracellular production of IFN-γ in CD3+ T lymphocytes from the patient in response to rhIL-12p70.

Conclusions

To our knowledge, this is the third patient with MSMD due to IL-12Rβ1 deficiency complicated with enteropathy and hypogammaglobulinemia and the first case of this disease to be described in Colombia.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bustamante J-C, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014 Dec;26(6):454–70.
    Article CAS PubMed PubMed Central Google Scholar
  2. de Beaucoudrey L, Samarina A, Bustamante J-C, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine. 2010 Nov 1;89(6):381–402.
    Article PubMed PubMed Central Google Scholar
  3. Ouederni M, Sanal Ö, Ikinciogullari A, Tezcan İ, Dogu FE, Sologuren I, et al. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis. 2014 Jan;58(2):204–13.
    Article CAS PubMed Google Scholar
  4. Van De Vosse E, Haverkamp MH, Ramírez-Alejo N, Martinez-Gallo M, Blancas-Galicia L, Metin A, et al. IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat. 2013 Oct;34(10):1329–39.
    Article PubMed PubMed Central Google Scholar
  5. de Jong BC, Onipede A, Pym AS, Gagneux S, Aga RS, DeRiemer K, et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol. 2005 Jul;43(7):3530–2.
    Article PubMed PubMed Central Google Scholar
  6. Singh S, Kumar M, Singh P. Evolution of M. bovisBCG vaccine: is niacin production still a valid biomarker? Tuberculosis Research and Treatment. 2015;2015(2):1–11.
    Article CAS Google Scholar
  7. Boisson-Dupuis S, Baghdadi El J, Parvaneh N, Bousfiha AA, Bustamante J-C, Feinberg J, et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011;6(4):e18524.
    Article CAS PubMed PubMed Central Google Scholar
  8. Boisson-Dupuis S, Bustamante J-C, Baghdadi El J, Camcioglu Y, Parvaneh N, Azbaoui El S, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015 Mar;264(1):103–20.
    Article CAS PubMed PubMed Central Google Scholar
  9. Condino-Neto A, Sorensen RU, Gómez Raccio AC, King A, Espinosa-Rosales FJ, Franco JL. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). Allergol Immunopathol (Madr). 2015 Sep;43(5):493–7.
    Article CAS Google Scholar
  10. Barreto SM, Miranda JJ, Figueroa JP, Schmidt MI, Munoz S, Kuri-Morales PP, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol. 2012 Apr;41(2):557–71.
    Article PubMed PubMed Central Google Scholar
  11. Pedraza-Sánchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordoñez M, González-Hernández Y, Sada-Díaz E, et al. Bacille Calmette–Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int J Infect Dis. 2010;14:e256–60.
    Article PubMed Google Scholar
  12. Schejbel L, Rasmussen EM, Kemp HB, Lundstedt AC, Nielsen KR, Obel N, et al. Combined IL-12 receptor and IgA deficiency in an adult man intestinally infested by an unknown, non-cultivable mycobacterium. Scand J Immunol. 2011 Dec;74(6):548–53.
    Article CAS PubMed Google Scholar
  13. Strickler A, Pérez A, Risco M, Gallo S. Bacillus Calmette-Guérin (BCG) disease and interleukin 12 receptor β1 deficiency: clinical experience of two familial and one sporadic case. Rev Chil Infectol. 2014 Aug;31(4):444–51.
    Article Google Scholar
  14. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med. 1994;330(19):1348–55.
    Article CAS PubMed Google Scholar
  15. Ulrichs T, Fieschi C, Nevicka E, Hahn H, Brezina M, Kaufmann SHE, et al. Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12R?1-deficient Slovakian children. Eur J Pediatr. 2005;164(3):166–72.
    Article CAS PubMed Google Scholar
  16. Alangari AA, Al-Zamil F, Al-Mazrou A, Al-Muhsen S, Boisson-Dupuis S, Awadallah S, et al. Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12R β1 deficiency. Clin Dev Immunol. 2011;2011(8):1–5.
    Article Google Scholar
  17. Baldo BA. Side effects of cytokines approved for therapy. Drug Saf. 2014 Nov;37(11):921–43.
    Article CAS PubMed Google Scholar
  18. Bedoya G, Montoya P, García J, Soto I, Bourgeois S, Carvajal L, et al. Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7234–9.
    Article CAS PubMed PubMed Central Google Scholar
  19. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012 Feb;1250(1):62–72.
    Article CAS PubMed Google Scholar
  20. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. (2010) Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection—United States, 2010. Vol. 59, MMWR Recommendations and reports: morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control. pp. 1–25.
  21. Group of Pediatric Immunology, Zelazko M, Liberatore D, Galicchio M, Pérez N, Regairaz L, et al. Comment on: advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72. Ann N Y Acad Sci. 2013 Dec;1306(1):71–2
    Article Google Scholar

Download references

Acknowledgments

We thank Yelena Nemirovskaya, Carolyn Álvarez, and Lahouari Amar for their administrative support and Claudia Llerena of the National Institute of Health in Bogotá (Colombia) for her assistance with microbiological analyses. This research was funded by the Colombian Administrative Department of Science, Technology and Innovation Colciencias (contract: 111556934990), Colciencias-ECOS NORD (contract: 619-2013), Group of Primary Immunodeficiencies and Fundación Diana García de Olarte para las Inmunodeficiencias Primarias-FIP-(Colombia), the National Institute of Allergy and Infectious Diseases grant number 5R01AI089970, the National Center for Research Resources and the National Center for Advancing Sciences of the National Institutes of Health grant number 8UL1TR000043, The Rockefeller University, the St. Giles Foundation, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Descartes University, Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID), and the French National Research Agency (ANR-GENMSMD ANR-16-CE17-0005-01 for JB) under the “Investments for the future” (grand number ANR-10-IAHU-01).

Author information

Author notes

  1. Natalia González
    Present address: Fundación Universitaria de las Américas, Pereira, Colombia
  2. Andrés Augusto Arias and Carlos M. Perez-Velez, Jacinta Bustamante, and José Luis Franco contributed equally to this work

Authors and Affiliations

  1. Grupo de Inmunodeficiencias Primarias, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No, 52-21, Medellín, Colombia
    Andrés Augusto Arias, Carlos M. Perez-Velez, Julio César Orrego, Marcela Moncada-Velez, Jessica Lineth Rojas, Catalina Arango-Ferreira, Diana Fernández, Johana Marcela Isaza-Correa, Diego Eduardo Gongóra, Daniel Gonzalez-Loaiza & José Luis Franco
  2. Escuela de Microbiología, Universidad de Antioquia UdeA, Calle 70 No, 52-21, Medellín, Colombia
    Andrés Augusto Arias
  3. Tuberculosis Clinic, Pima County Health Department, Tucson, USA
    Carlos M. Perez-Velez
  4. Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, USA
    Carlos M. Perez-Velez
  5. Hospital Universitario San Vicente Fundación, Medellin, Colombia
    Alejandra Wilches & Catalina Arango-Ferreira
  6. Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No, 52-21, Medellín, Colombia
    Alejandra Wilches, Carlos Garcés, Catalina Arango-Ferreira & Juan Esteban Sierra
  7. Departamento de Pediatría, Hospital Pablo Tobon Uribe, Medellin, Colombia
    Andrea Restrepo, Mónica Trujillo & Carlos Garcés
  8. Clínica Universitaria Bolivariana, Medellin, Colombia
    Andrea Restrepo
  9. Hospital Infantil Rafael Henao Toro, Manizales, Colombia
    Natalia González
  10. Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France
    Carmen Oleaga-Quintas, Jean Laurent Casanova & Jacinta Bustamante
  11. Paris Descartes University, Imagine Institute, Paris, France
    Carmen Oleaga-Quintas, Jean Laurent Casanova & Jacinta Bustamante
  12. Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France
    Jean Laurent Casanova
  13. Howard Hughes Medical Institute, New York, USA
    Jean Laurent Casanova
  14. St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller branch, The Rockefeller University, New York, NY, USA
    Jean Laurent Casanova & Jacinta Bustamante
  15. Center for the Study of Primary Immunodeficiencies, Necker Hospital for Sick Children, AP-HP, Paris, France
    Jacinta Bustamante

Authors

  1. Andrés Augusto Arias
  2. Carlos M. Perez-Velez
  3. Julio César Orrego
  4. Marcela Moncada-Velez
  5. Jessica Lineth Rojas
  6. Alejandra Wilches
  7. Andrea Restrepo
  8. Mónica Trujillo
  9. Carlos Garcés
  10. Catalina Arango-Ferreira
  11. Natalia González
  12. Carmen Oleaga-Quintas
  13. Diana Fernández
  14. Johana Marcela Isaza-Correa
  15. Diego Eduardo Gongóra
  16. Daniel Gonzalez-Loaiza
  17. Juan Esteban Sierra
  18. Jean Laurent Casanova
  19. Jacinta Bustamante
  20. José Luis Franco

Corresponding author

Correspondence toJosé Luis Franco.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

About this article

Cite this article

Arias, A.A., Perez-Velez, C.M., Orrego, J.C. et al. Severe Enteropathy and Hypogammaglobulinemia Complicating Refractory Mycobacterium tuberculosis Complex Disseminated Disease in a Child with IL-12Rβ1 Deficiency.J Clin Immunol 37, 732–738 (2017). https://doi.org/10.1007/s10875-017-0435-1

Download citation

Keywords